Back to results
US 12,258,304 B2Granted
Compounds and methods for treatment of bacterial infections
AssigneesAlbert Einstein College of Medicine, Victoria Link Limited
InventorsSteven C. Almo, Tyler Grove, Lawrence D. Harris, Gary B. Evans
Life of this patent
Estimating the term…
Abstract
This document discloses a novel class of compounds for inhibiting bacterial growth and treating bacterial infection. The compounds target a key step of the futalosine pathway and therefore are effective for the selective inhibition of certain bacterial species and genera with reduced side effect in comparison with conventional antibiotics.
Claims20
A compound or a pharmaceutically acceptable salt thereof, wherein the compound is represented by Formula I,
- wherein:
- R1 in each instance independently is hydrogen or C1-10alkyl, wherein the C1-10alkyl is optionally substituted with one or more selected from the group consisting of a halogen, oxo (═O), OH, OC1-4alkyl, SC1-4alkyl, and arylC1-6alkyl;
- R2, R3, R4, and R5 are each independently selected from the group consisting of hydrogen, fluorine, chlorine, bromine, C1-4alkyl, CN, C1-6alkylCONH, C1-6alkylNHCO, C1-6alkylSO2NH, C1-6alkylNHSO2, and C1-6alkylSO2;
- X is O, S, NH or CH2;
- and
- Z in each instance independently is C or N, provided that:
- when a Z is N, the substituent R2, R3, R4, or R5 attached thereto is void;
- and
- when each Z is C, at least one of R2, R3, R4, and R5 is chlorine or fluorine.
6 more elements
Dependencies are inferred from the claim text.